(Q34621558)

3 August 2017

title

Five-year safety and efficacy of belatacept in renal transplantation (English)

1 reference

3 August 2017

12

Jean-Paul Soulillou

1 reference

3 August 2017

7

Jurgen Klempnauer

1 reference

3 August 2017

6

Philip F Halloran

1 reference

3 August 2017

Flavio Vincenti

1

1 reference

3 August 2017

Gilles Blancho

2

1 reference

3 August 2017

Antoine Durrbach

3

1 reference

3 August 2017

Peter Friend

4

1 reference

3 August 2017

Josep Grinyo

5

1 reference

3 August 2017

Philippe Lang

8

1 reference

3 August 2017

Christian P Larsen

9

1 reference

3 August 2017

Ferdinand Mühlbacher

10

1 reference

3 August 2017

Björn Nashan

11

1 reference

3 August 2017

Yves Vanrenterghem

13

1 reference

3 August 2017

Thomas Wekerle

14

1 reference

3 August 2017

Mamta Agarwal

15

1 reference

3 August 2017

Sheila Gujrathi

16

1 reference

3 August 2017

Jinshan Shen

17

1 reference

3 August 2017

Rebecca Shi

18

1 reference

3 August 2017

Robert Townsend

19

1 reference

3 August 2017

Bernard Charpentier

20

1 reference

3 August 2017

publication date

15 July 2010

1 reference

Journal of the American Society of Nephrology

3 August 2017

published in

1 reference

3 August 2017

volume

21

1 reference

3 August 2017

issue

9

1 reference

3 August 2017

page(s)

1587-1596

1 reference

Polyomavirus in renal transplantation: a hot problem.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Cardiovascular toxicities of immunosuppressive agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Strategies to improve long-term outcomes after renal transplantation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study).

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Assessment of belatacept-mediated costimulation blockade through evaluation of CD80/86-receptor saturation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Chronic kidney disease in renal transplant recipients.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Costimulation blockade with belatacept in renal transplantation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Performance of different prediction equations for estimating renal function in kidney transplantation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Predicting kidney graft failure using time-dependent renal function covariates

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

The change in allograft function among long-term kidney transplant recipients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3013525

Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors

26 October 2018

1 reference

12 December 2020

A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)

1 reference

12 December 2020

Late urinary tract infection after renal transplantation in the United States

1 reference

12 December 2020

Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

1 reference

12 December 2020

Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2009111109

1 reference

3 August 2017

1 reference

3 August 2017

1 reference